Establishment and Composition. Within 30 days of the Effective Date, the Parties shall establish the Committee (“Committee”) to oversee Product development and clinical studies, with Perrigo having the right to appoint up to 2 representatives on the Committee and Sol-Gel having the right to appoint up to 2 representatives of the Committee. One Committee member of each Party shall also be designated as the primary contact person for his or her respective Party. One of the representatives selected by Sol-Gel shall chair the Committee.
Appears in 3 contracts
Sources: Development, Manufacturing and Commercialization Agreement, Development, Manufacturing and Commercialization Agreement (Sol-Gel Technologies Ltd.), Development, Manufacturing and Commercialization Agreement (Sol-Gel Technologies Ltd.)